143 related articles for article (PubMed ID: 28670694)
1. Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: a multicenter cross-sectional study.
Liao XZ; Shi JF; Liu JS; Huang HY; Guo LW; Zhu XY; Xiao HF; Wang L; Bai YN; Liu GX; Mao AY; Ren JS; Sun XJ; Mai L; Liu YQ; Song BB; Gong JY; Zhou JY; Du LB; Zhou Q; Cao R; Zhu L; Ren Y; Lou PA; Lan L; Sun XH; Qi X; Wang YZ; Zhang K; He J; Dai M;
Asia Pac J Clin Oncol; 2018 Jun; 14(3):167-178. PubMed ID: 28670694
[TBL] [Abstract][Full Text] [Related]
2. Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study.
Zhang K; Yin J; Huang H; Wang L; Guo L; Shi J; Dai M
Front Public Health; 2020; 8():310. PubMed ID: 32850573
[No Abstract] [Full Text] [Related]
3. Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey.
Huang HY; Shi JF; Guo LW; Bai YN; Liao XZ; Liu GX; Mao AY; Ren JS; Sun XJ; Zhu XY; Wang L; Song BB; Du LB; Zhu L; Gong JY; Zhou Q; Liu YQ; Cao R; Mai L; Lan L; Sun XH; Ren Y; Zhou JY; Wang YZ; Qi X; Lou PA; Shi D; Li N; Zhang K; He J; Dai M
Chin J Cancer; 2017 Apr; 36(1):41. PubMed ID: 28454595
[TBL] [Abstract][Full Text] [Related]
4. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).
Guo LW; Huang HY; Shi JF; Lv LH; Bai YN; Mao AY; Liao XZ; Liu GX; Ren JS; Sun XJ; Zhu XY; Zhou JY; Gong JY; Zhou Q; Zhu L; Liu YQ; Song BB; Du LB; Xing XJ; Lou PA; Sun XH; Qi X; Wu SL; Cao R; Lan L; Ren Y; Zhang K; He J; Zhang JG; Dai M;
Chin J Cancer; 2017 Sep; 36(1):73. PubMed ID: 28882179
[TBL] [Abstract][Full Text] [Related]
5. [Economic burden of esophageal cancer in China from 1996 to 2015: a systematic review].
Guo LW; Shi CL; Huang HY; Wang L; Yue XP; Liu SZ; Li J; Su K; Dai M; Sun XB; Shi JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):102-109. PubMed ID: 28100387
[No Abstract] [Full Text] [Related]
6. [Economic burden of cancer in China during 1996-2014: a systematic review].
Shi JF; Shi CL; Yue XP; Huang HY; Wang L; Li J; Lou PA; Mao AY; Dai M
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):929-941. PubMed ID: 27998471
[No Abstract] [Full Text] [Related]
7. [Standard treatment cost of female breast cancer at different TNM stages].
Li H; Huang Y; Huang R; Li JY
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):946-50. PubMed ID: 24506967
[TBL] [Abstract][Full Text] [Related]
8. No expenditure difference among patients with liver cancer at stage I
Lei H; Lei L; Shi J; Wu Y; Liang L; Huang H; He M; Bai F; Cao M; Qiu H; Wang Y; Liu C; Du J; Wang H; Zhang Y; Cao M; Peng J; Li N; Qu C; Dai M; Chen W; He J
Chin J Cancer Res; 2020 Aug; 32(4):516-529. PubMed ID: 32963464
[TBL] [Abstract][Full Text] [Related]
9. Medical expenditure for liver cancer in urban China: A 10-year multicenter retrospective survey (2002-2011).
Qiu WQ; Shi JF; Guo LW; Mao AY; Huang HY; Hu GY; Dong P; Bai FZ; Yan XL; Liao XZ; Liu GX; Bai YN; Ren JS; Sun XJ; Zhu XY; Zhou JY; Gong JY; Zhu L; Mai L; Du LB; Zhou Q; Xing XJ; Song BB; Liu YQ; Lou PA; Sun XH; Wu SL; Cao R; Qi X; Lan L; Ren Y; Zhang K; He J; Qu C; Dai M
J Cancer Res Ther; 2018 Jan; 14(1):163-170. PubMed ID: 29516981
[TBL] [Abstract][Full Text] [Related]
10. Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi.
Pakseresht S; Ingle GK; Garg S; Singh MM
Indian J Cancer; 2011; 48(4):428-37. PubMed ID: 22293256
[TBL] [Abstract][Full Text] [Related]
11. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Mao W; Tang S; Zhu Y; Xie Z; Chen W
Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
[TBL] [Abstract][Full Text] [Related]
12. Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002
Shi J; Liu G; Wang H; Mao A; Liu C; Guo L; Huang H; Ren J; Liao X; Bai Y; Sun X; Zhu X; Wang J; Song B; Zhou J; Zhu L; Lei H; Liu Y; Liu Y; Du L; He Y; Zhang K; Li N; Chen W; Dai M; He J
Chin J Cancer Res; 2019 Oct; 31(5):825-837. PubMed ID: 31814686
[TBL] [Abstract][Full Text] [Related]
13. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China.
Jing J; Feng R; Zhang X; Li M; Gao J
Breast Cancer Res Treat; 2020 Jun; 181(2):435-443. PubMed ID: 32306169
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Medical Expenditure for Patients With Breast Cancer in China: Evidence From Current Curative Expenditure by System of Health Accounts 2011.
Zheng A; Zhu Y; Wang Y; Liu F; Jin F; Zang S; Wang X
Value Health; 2022 Jan; 25(1):77-83. PubMed ID: 35031102
[TBL] [Abstract][Full Text] [Related]
15. [Economic burden of stomach cancer in China during 1996-2015: a systematic review].
Yao F; Shi CL; Liu CC; Wang L; Song SM; Ren JS; Guo CG; Lou PA; Dai M; Zhu L; Shi JF
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):756-762. PubMed ID: 28763928
[No Abstract] [Full Text] [Related]
16. Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study.
Chen H; Zhao X; Hu S; You T; Xia C; Gao M; Dong M; Qiao Y; Zhao F
Chin J Cancer Res; 2023 Dec; 35(6):675-685. PubMed ID: 38204443
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer: a pilot study.
Mullins CD; Wang J; Cooke JL; Blatt L; Baquet CR
Pharmacoeconomics; 2004; 22(5):285-91. PubMed ID: 15061678
[TBL] [Abstract][Full Text] [Related]
18. Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China.
Xin XX; Zhao L; Guan XD; Shi LW
Chin Med J (Engl); 2016 Jun; 129(12):1387-93. PubMed ID: 27270531
[TBL] [Abstract][Full Text] [Related]
19. Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea.
Han S; Jang BH; Suh HS; Hwang DS
Complement Ther Med; 2019 Jun; 44():210-217. PubMed ID: 31126558
[TBL] [Abstract][Full Text] [Related]
20. Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
Héquet D; Huchon C; Soilly AL; Asselain B; Berseneff H; Trichot C; Combes A; Alves K; Nguyen T; Rouzier R; Baffert S
PLoS One; 2019; 14(7):e0210917. PubMed ID: 31291250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
